loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 2389169 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 METFORMIN HYDROCHLORIDE (1)

02 SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) (1)

filter

01 ASTRAZENECA CANADA INC (2)

filter

01 TABLET (2)

filter

01 2.5MG (1)

02 500MG (1)

filter

01 Canada (2)

URL Supplier Web Content
TABLET
2.5MG
KOMBOGLYZE
Canada
2389169
60
Prescription
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET
500MG
KOMBOGLYZE
Canada
2389169
60
Prescription
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2389169

Looking for CTD TGA MCC DOSSIER APPLICATION 2389169 2

19

AstraZeneca, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE), with a corresponding application number 2389169 and regulatory information .

proudly manufactured in the

AstraZeneca's KOMBOGLYZE TABLET, medication with 2.5MG of SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE).

18

AstraZeneca, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is METFORMIN HYDROCHLORIDE, with a corresponding application number 2389169 and regulatory information .

proudly manufactured in the

AstraZeneca's KOMBOGLYZE TABLET, medication with 500MG of METFORMIN HYDROCHLORIDE.

Post Enquiry
POST ENQUIRY